0.00Open0.05Pre Close0 Volume3.42K Open Interest0.50Strike Price0.00Turnover5250.55%IV37.16%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier-4DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.4300Delta1.8835Gamma8.03Leverage Ratio-1.1474Theta0.0000Rho3.45Eff Leverage0.0000Vega
Sangamo Therapeutics Stock Discussion
Sangamo Therapeutics recently presented critical pre-clinical data on its innovative next-generation integrase technology, the Modular Integrase (MINT) platform, highlighting a significant advancement in the field of genome editing. The announcement came as part of their participation at the 27th Amer...
No comment yet